CytomX Therapeutics, Inc. ($CTMX)
Ogden Christopher โ Chief Financial Officer
Shares
1,624
Price
$3.05
Total Value
$4,953.20
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Ogden Christopher |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Jun 15, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jun 17, 2026 |
| Shares Sold | 1,624 |
| Price per Share | $3.05 |
| Total Value | $4,953.20 |
| Shares Owned After | 295,324 |
| Derivative | No |
| Accession Number | 0001610717-26-000229 |
| Document | View SEC Filing |